Clinical trial
Study Evaluating the Safety and Efficacy of Etanercept in Patients With…
NCT00293709 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00293709 |
|---|---|
| Title | Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists |
| Official title | Prospective Post Marketing Surveillance To Evaluate The Safety And Efficacy Of Etanercept Under Usual Care Settings In Patients With Psoriatic Arthritis (Psa) Treated By Dermatologists |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Arthritis, Psoriatic, Psoriasis, Skin Diseases, Papulosquamous |
| Intervention type | Drug |
| Interventions | etanercept |
| Enrollment | 129 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Feb 17, 2006 |
| Last update posted | Feb 26, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: